Skip Navigation

This Article
Right arrow Print PDF (1253K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (106)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Laimins, L. A.
Right arrow Articles by Khoury, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laimins, L. A.
Right arrow Articles by Khoury, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1984, Vol. 12, No. 16 6427-6442
© 1984


MOLECULAR BIOLOGY

Multiple enhancer domains in the 3' terminus of the Prague strain of Rous sarcoma virus

Laimonis A. Laimins, Philip Tsichlis1 and George Khoury

Laboratory of Molecular Virology, National Cancer Institute, National Institutes of Health Building 41, Suite 200, Bethesda, MD 20205 1The Institute for Cancer Research, Fox Chase Cancer Center Philadelphia, PA 19111, USA

Received May 30, 1984. Accepted July 18, 1984.

The 3' terminal region of the Prague strain of Rous sarcoma virus (PrRSV) contains at least three distinct domains that comprise two func tional enhancer elements. Two of these domains (designated B and C) are found in the U3 region of the 3' long terminal repeat (LTR) while the third (designated A) is located in the sequences immediately preceding the LTR termed XSR sequences. Combinations of adjacent domains [e.g., (A + B or B + C)] are capable of activating the expression of the SV4O early promoter (21 bp repeats and TATA box) coupled to coding sequences from the prokaryotic gene chloramphenicol acetyltransferase (CAT) while a single domain is inactive. Furthermore, duplication or triplication of the central domain B restores activity. The related, Schmidt-Ruppin, strain of RSV, contains an almost identical 3' LTR element, but differs in the enhan cer sequences immediately preceding the 3' LTR. A model is presented in which the sequence differences may contribute to the difference in disease spectrum of transformation defective (td) variants of these viruses.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
P. M. Chesters, L. P. Smith, and V. Nair
E (XSR) element contributes to the oncogenicity of Avian leukosis virus (subgroup J)
J. Gen. Virol., September 1, 2006; 87(9): 2685 - 2692.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. R. Broussard, J. A. Mertz, M. Lozano, and J. P. Dudley
Selection for c-myc Integration Sites in Polyclonal T-Cell Lymphomas
J. Virol., March 1, 2002; 76(5): 2087 - 2099.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Benson, B. L. Ruis, A. L. Garbers, A. M. Fadly, and K. F. Conklin
Independent Isolates of the Emerging Subgroup J Avian Leukosis Virus Derive from a Common Ancestor
J. Virol., December 1, 1998; 72(12): 10301 - 10304.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. M. Mobley and L. Sealy
Role of the Transcription Start Site Core Region and Transcription Factor YY1 in Rous Sarcoma Virus Long Terminal Repeat Promoter Activity
J. Virol., August 1, 1998; 72(8): 6592 - 6601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-H. Yeh and A. J. Shatkin
A cis-Acting Element in Rous Sarcoma Virus Long Terminal Repeat Required for Promoter Repression by HeLa Nuclear Protein p21
J. Biol. Chem., June 30, 1995; 270(26): 15815 - 15820.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S Fiering, J P Northrop, G P Nolan, P S Mattila, G R Crabtree, and L A Herzenberg
Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor.
Genes & Dev., October 1, 1990; 4(10): 1823 - 1834.
[Abstract] [PDF]


Home page
Genes Dev.Home page
C Roman, J S Platero, J Shuman, and K Calame
Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.
Genes & Dev., August 1, 1990; 4(8): 1404 - 1415.
[Abstract] [PDF]


Home page
Genes Dev.Home page
A Dutta, M Y Stoeckle, and H Hanafusa
Serum and v-src increase the level of a CCAAT-binding factor required for transcription from a retroviral long terminal repeat.
Genes & Dev., February 1, 1990; 4(2): 243 - 254.
[Abstract] [PDF]


Home page
Genes Dev.Home page
S Schirm, J Jiricny, and W Schaffner
The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity.
Genes & Dev., March 1, 1987; 1(1): 65 - 74.
[Abstract] [PDF]


Home page
ScienceHome page
P. Overbeek, S. Lai, K. Van Quill, and H Westphal
Tissue-specific expression in transgenic mice of a fused gene containing RSV terminal sequences
Science, March 28, 1986; 231(4745): 1574 - 1577.
[Abstract] [PDF]


Home page
ScienceHome page
D Derse and J. Casey
Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression
Science, March 21, 1986; 231(4744): 1437 - 1440.
[Abstract] [PDF]


Home page
ScienceHome page
M Linial, N Gunderson, and M Groudine
Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis
Science, December 6, 1985; 230(4730): 1126 - 1132.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.